Zacks Investment Research
13 Oct 2026, 22:50 UTC · 1h ago
Impact · against what's priced in
The article provides no new catalysts for Medtronic, merely reiterating consensus EPS and revenue estimates that are already factored into the current valuation. The stock's recent outperformance of the S&P 500 is a technical observation rather than a fundamental shift.
Scored by the NIS engine · methodology.
Search tags
What the story claims
3 claims · scored −1 bearish … +1 bullish · 0 new · 3 priced in
Medtronic is predicted to post a quarterly EPS of $1.34, representing a 1.47% decline year-over-year.
Priced inanalysis of consensus estimates
So whatA miss on this $1.34 estimate during the upcoming print could trigger a downward revision of the $5.98 annual EPS target.
More negative than 77% of claims this week
Consensus estimates call for quarterly revenue of $9.47 billion, an increase of 5.66% from the prior year.
Continue reading
5 related stories
Priced inanalysis of consensus estimates
So whatRevenue growth of ~5.7% suggests top-line expansion that may offset the projected slight EPS dip.
More positive than 55% of claims this week
Medtronic's Forward P/E ratio of 15.38 is at a discount compared to the industry average of 19.61.
Priced invaluation analysis
So whatThe ~22% discount to industry peers provides a valuation cushion if the stock faces near-term volatility.
More positive than 45% of claims this week
Which stocks this story touches
More positive than 52% of ticker scores this week
The stock outperformed the S&P 500 in the latest session and has positive annual revenue and earnings growth forecasts.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
